Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • A study of finerenone added to standard treatment in children aged 6 months to under 18 years with heart failure and reduced left heart pumping function

    Recruiting

    3 1
    Investigated Drugs:
    Austria Belgium Bulgaria Czechia Finland Germany +7
  • Effect of Acetazolamide Added to Standard Therapy on Weight Reduction and Symptom Relief in Patients with Heart Failure

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Effect of Continuing vs Stopping Dapagliflozin (with other drug combinations) on 30‑Day Cardiovascular Outcomes in Heart Failure Patients Undergoing Cardiac Surgery

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    France
  • A feasibility study of dapagliflozin for elderly patients hospitalized with chronic heart failure.

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    France
  • Study of cardiac atrial stem cells injected into heart muscle for treating advanced heart failure in patients with prior heart attack and reduced heart function

    Not yet recruiting

    2 1 1
    Belgium
  • Study on COR-1167 for Patients with Worsening Heart Failure

    Not yet recruiting

    2 1
    Investigated Diseases:
    Czechia Hungary Poland Romania Spain
  • Study on the Effects of Dobutamine and Levosimendan in Patients with Heart Failure and Reduced Left Ventricular Function

    Not yet recruiting

    3 1 1 1
    Spain
  • A Study of High-Concentration Oxygen Treatment in Patients with Heart Failure, Pulmonary Hypertension, and Coronary Microvascular Dysfunction

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    The Netherlands
  • Preventing Heart Failure in Early Breast Cancer Patients Receiving Anthracycline Therapy with Sacubitril and Valsartan (LCZ696)

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Norway
  • A study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Bulgaria Croatia Czechia Denmark +18